Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3HA4

Crystal structure of the type one membrane protein MIX1 from Leishmania

Summary for 3HA4
Entry DOI10.2210/pdb3ha4/pdb
DescriptorMIX1, CARBONATE ION (3 entities in total)
Functional Keywordstpr-like, helix-turn-helix, unknown function
Biological sourceLeishmania major
Total number of polymer chains8
Total formula weight141445.21
Authors
Gorman, M.A.,Walsh, P.J.,Parker, M.W. (deposition date: 2009-05-01, release date: 2010-05-05, Last modification date: 2024-02-21)
Primary citationGorman, M.A.,Uboldi, A.D.,Walsh, P.J.,Tan, K.S.,Hansen, G.,Huyton, T.,Ji, H.,Curtis, J.,Kedzierski, L.,Papenfuss, A.T.,Dogovski, C.,Perugini, M.A.,Simpson, R.J.,Handman, E.,Parker, M.W.
Crystal structure of the Leishmania major MIX protein: A scaffold protein that mediates protein-protein interactions.
Protein Sci., 20:1060-1068, 2011
Cited by
PubMed Abstract: Infection by Leishmania and Trypanosoma causes severe disease and can be fatal. The reduced effectiveness of current treatments is largely due to drug resistance, hence the urgent need to develop new drugs, preferably against novel targets. We have recently identified a mitochondrial membrane-anchored protein, designated MIX, which occurs exclusively in these parasites and is essential for virulence. We have determined the crystal structure of Leishmania major MIX to a resolution of 2.4 Å. MIX forms an all α-helical fold comprising seven α-helices that fold into a single domain. The distribution of helices is similar to a number of scaffold proteins, namely HEAT repeats, 14-3-3, and tetratricopeptide repeat proteins, suggesting that MIX mediates protein-protein interactions. Accordingly, using copurification and mass spectroscopy we were able to identify several proteins that may interact with MIX in vivo. Being parasite specific, MIX is a promising new drug target and, thus, the structure and potential interacting partners provide a basis for structure-guided drug discovery.
PubMed: 21465610
DOI: 10.1002/pro.631
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon